康弘药业(002773.SZ)：米拉贝隆缓释片收到药品注册证书

Core Viewpoint - Kanghong Pharmaceutical (002773.SZ) has received the Drug Registration Certificate for Mirabegron Extended-Release Tablets from the National Medical Products Administration, indicating regulatory approval for the product [1] Group 1 - The Drug Registration Certificate number for Mirabegron is 2025S03430 [1] - Mirabegron is a selective β3 adrenergic receptor agonist that relaxes bladder smooth muscle by acting on bladder tissue [1]